Introduction
Male infertility is a common concern among couples trying to conceive. One important factor that affects male fertility is sperm morphology, which refers to the size and shape of sperm. When a large number of sperm have an abnormal shape, the condition is known as teratozoospermia or abnormal sperm morphology.
Many couples worry after receiving an abnormal semen analysis report. However, having abnormal sperm shape does not mean that pregnancy is impossible. With proper evaluation and advanced fertility treatments, many men with abnormal sperm morphology can achieve successful conception.
A healthy sperm usually has:
In abnormal sperm morphology, sperm may have:
These structural changes may affect the sperm’s ability to swim properly and fertilize the egg.
Abnormal sperm morphology can reduce the chances of natural conception, but it does not always mean complete infertility.
Fertility depends on multiple sperm factors, including:
A detailed semen analysis and fertility evaluation help doctors understand the severity of the problem and decide the best treatment approach.
Several factors can affect sperm development and quality:
Oxidative stress can damage developing sperm cells and affect their shape and function.
Enlarged veins around the testicles can increase temperature and negatively affect sperm production.
Changes in reproductive hormones may interfere with sperm formation.
Certain infections and health conditions may impact sperm quality.
Diagnosis is usually done through:
A semen test evaluates:
Sometimes doctors may recommend additional tests such as:
Yes. Treatment depends on the underlying cause and severity.
Improving lifestyle habits may help improve sperm quality:
✔ Stop smoking
✔ Reduce alcohol intake
✔ Maintain healthy weight
✔ Exercise regularly
✔ Eat antioxidant-rich foods
✔ Avoid excessive heat exposure to the testicles
If a medical problem such as hormonal imbalance, infection, or varicocele is identified, treating that condition may improve sperm parameters.
In selected cases, doctors may recommend supplements containing antioxidants that support sperm health. These should be taken only after medical advice.
When abnormal sperm morphology significantly affects fertilization, advanced assisted reproductive techniques can help.
In ICSI, a fertility specialist selects a healthy-looking sperm and injects it directly into the egg to assist fertilization. ICSI is commonly considered in cases with abnormal semen parameters, including male-factor infertility.
At Akanksha IVF Centre, Delhi, fertility specialists evaluate each couple individually and recommend treatment based on:
You should consider a fertility evaluation if:
Early evaluation can help identify the right treatment pathway.
Abnormal sperm shape is a treatable condition. A diagnosis of abnormal morphology does not mean you cannot become a father. With lifestyle changes, medical support, and advanced fertility treatments like IVF and ICSI, many couples can achieve their dream of parenthood.
If you are facing male infertility concerns, consult the fertility experts at Best IVF Centre Delhi Delhi for a personalized evaluation and treatment plan.
Book your consultation today and take the first step towards your parenthood journey.
Visit: www.akankshaivfcentre.com
Presently Chief Consultant Infertility & IVF at Akanksha IVF Centre,since July 2001 in Mata Chanan Devi Hospital, a 225 bedded Superspeciality hospital in South West Delhi. Akanksha IVF Centre was established by me to provide comprehensive facilities for Assisted Reproductive Techniques of International quality control standards, performing about 600 to 700 IVF/ICSI cycles annually.
Area of Expertise : Infertility & IVF
Akanksha IVF Centre Certified Infertility management Courses in Clinical ART & Embryology (Since 2001).
Conducting FOGSI Certified Infertility Trainings (Since 2014) Basic & Advanced Infertility Training and IUI
Poor Ovarian Responders & recurrent implantation failures.
Indian Fertility Society Guideline On Poor Ovarian Response-2024
ASRM
| Year | Place | Title |
| October 23rd-25th 2006. | ASRM, New Orleans, USA | POSTER “Comparative study of various semen preparation techniques in IUI and their effect on pregnancy”. |
| October 13th – 17th 2007. | Washington | POSTER “Sperm cryosurvival using minimal semen volume in test vial”. |
| November. 8th – 12th 2008. | San Francisco, USA | Round Table interactive session on “Aromatase inhibitors for enhancing outcome of ART”. |
| November. 8th – 12th 2008. | San Francisco, USA | Published: Clomiphene citrate vs. Low dose recombinant FSH for ovarian stimulation in Intra Uterine Insemination cycles for unexplained and male infertility. |
| October 17th – 21st 2009. | Atlanta, USA | Round Table interactive session on “Fertility Treatment of PCOS”. |
| October 25th – 27th 2010. | Denver, USA | POSTER “A Newer approach for ovarian stimulation in poor responders undergoing IVF”. |
| October 15th – 19th, 2011. | Orlando, USA | POSTER(1)“Does pelvic tuberculosis affect the ovarian reserve and the oocyte in patients undergoing IVF”.
POSTER (2) “Is AFC a better markers then AMH & FSH in predicting the number of oocytes retrieved in women undergoing ovarian stimulation for IVF”. |
| October14th- 17th 2013. | Boston, USA | POSTER (1) “Choosing the right ovulation trigger in Antagonist cycle for an OHSS free clinic
POSTER (2) “Impact of Endometrial injury on successful outcome in IVF cycle”. |
| October 18th – 22nd2014. | Honolulu Hawaii, USA | ORAL:“Does Exogenous LH supplementation improve reproductive outcome in poor responder woman undergoing IVF/ICSI in GnRH Antagonist Protocol”. |
| October 17th– 21st 2015. | Baltimore, USA | POSTER “Scheduling Hysteroscopic endometrial Biopsy in Endometrial preparation cycles just preceding ET V/S any time in last one year – Does it changes Reproductive outcome. |
| October 16th – 20th 2016. |
Salt Lake City, USA | POSTER(1) “ Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS”. POSTER(2) “Dysregulated infertility-related genes in women with endometriosis”. |
| October 28th – 1st November 2017 | San Antonio, Texas, USA | POSTER (1) Elective frozen Vs. Fresh Embryo transfer in Antagonist cycles in normo-responders: a randomised study. POSTER (2) Dysregulated gene involved in implantation failure in women with endometriosis. POSTER (3) Yoga affects IVF outcomes ? |
| October 6th – 10th 2018 | Denver, Colorado USA |
ORAL “Adjuvant Recombinant LH (rLH) or Growth Hormone (GH) to the Antagonist protocol in poor responders undergoning IVF” POSTER “ Is time lapse a better option to improve clinical outcome over standard incubator – A case control study” |
| October 13th – 16th 2019 | Philadelphia, Pennsylvania, USA | POSTER “ Assessment of psychological distress in polycystic ovarian syndrome infertile patients at a tertiary level infertility care centre in India”. |
| October 17th – 21th 2020 | Portland, Oregon, USA | POSTER (1) Does controlled ovarian hyperstimulation response varies with PCOS phenotypes: A prospective cohort study at a tertiary infertility centre in INDIA. POSTER(2) Impact of endometriosis on anxiety, depression and quality of life and its association with pregnancy outcomes in infertile patients at a tertiary level infertility centre in INDIA. |
| October 17th – 20th 2021 | Baltimore, Maryland, USA | POSTER (1) Single step or sequential media in embryo culture: outcome in donor oocyte cycles POSTER (2) Comparison of microfluidic sperm sorting (MFSS) versus physiological intracytoplasmic sperm injection (PICSI) versus density gradient in high DNA fragmentation index sperm samples. POSTER (3) Transdermal oestradiol gel vs oral oestrogen for successful clinical outcome in hormone replacement Frozen embryo transfer (hr-FET) cycles- a prospective randomized controlled study. POSTER (4) Does dual trigger with combination of gonadotropin-releasing hormone agonist and low dose human chorionic gonadotropin improves clinical outcomes in normal responders in GnRH antagonist IVF- ICSI cycles. |
| October 24th – 26th 2022 | Anaheim,CA, USA | POSTER (1) Progesterone primed ovarian stimulation protocol (PPOS) vs GnRh antagonist for patients of freeze all cycles: a prospective randomised controlled trial. |
| October 14th – 18th 2023 | New Orleans, Louisiana, USA | “ORAL” (1) Impact of psychosocial support with meditation on IVF/ICSI clinical outcomes: a prospective cohort study. (2) Intramural fibroid in infertile women – Experience and Evidence. |
| October 20th – 23rd 2024 | Denver, USA | PG Course no. 13 (1) Alternative Stimulation Protocols in Assisted Reproductive Technology. (2) Complications and Risks in Ovarian Stimulation. Poster P 322 EFFECTIVENESS OF AUTOLOGOUS PLATELETRICH PLASMA (PRP) THERAPY FOR IMPROVING ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOMES IN WOMEN WITH THIN ENDOMETRIUM : A RANDOMISED CONTROLLED TRIAL |
IFFS
| 22nd World Congress September 24th – 28th 2016 23rd World CongressApril 11th to 14th2019 |
NCR, New Delhi
Shanghai, China |
Invited Speaker :
Oral
Posters:
Oral
|
| 24th World Congress September 10th-13th 2023 | Athens, Greece | Oral Can adjuvants and rejuvenative therapies increase ovarian reserve? Invited Expert |
| 25th World Congress April 26th-29th 2025 | Tokya, Japan | Posters:
Mid-luteal serum progesterone levels and pregnancy outcomes in frozen embryo transfer cycles: a prospective observational study ART outcomes in poor ovarian responders based on POSEIDON criteria in Indian women: a prospective observational study. |
ESHRE
| July 3rd -5th2017
July 2nd – 4th 2018 June 23rd – 26th 2019 July 5th -8th 2020 26th June-1st July 2021 |
Geneva, Switzerland33rd ESHRE congress
Barcelona, Spain Vienna , Austria Copenhagen, Denmak Paris, France |
Oral
Poster:
Posters:
Oral
Posters
Posters
Posters
|
| 03rd July-6stJuly 2022
25th to28thJune , 2023 8th to 10th July, 2024 |
Milan, Italy 38th ESHRE congresss Copenhangen, Denmark Amesterdam |
Invited Speaker:
Fibroid and fertility- To remove or not to remove debate continues.
Oral: Poster
Invited Speaker: Oral : |
